Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 2 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-12-11 Kwon Paul Chief Scientific Officer Exercise or conversion +80,300 80,300
2019-12-11 Kwon Paul Chief Scientific Officer Shares withheld for taxes −27,766 $4.52 $126K 52,534
2019-12-11 Kwon Paul Chief Scientific Officer Exercise or conversion · Restricted Stock Units −80,300 0
2019-12-11 Kwon Paul Chief Scientific Officer Exercise or conversion +80,300 80,300
2019-12-11 Kwon Paul Chief Scientific Officer Shares withheld for taxes −27,766 $4.52 $126K 52,534
2019-07-29 Kwon Paul Chief Scientific Officer Grant or award · Restricted Stock Units +80,300 396,812
2019-07-29 Kwon Paul Grant or award · Restricted Stock Units +80,300 396,812
2018-12-10 Kwon Paul Chief Scientific Officer Grant or award · Stock Option +64,000 64,000
2018-05-03 Kwon Paul Chief Medical Officer Grant or award · Stock Option +64,000 252,512

Page 1 of 1 · 9 trades